Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at America... PR Newswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on PTN
    Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
    7:30a ET February 9 '24 PR Newswire

    Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2024 operating results on Thursday, February 15, 2024, before the open of the U.S. financial markets.

    https://mma.prnewswire.com/media/464561/Palatin_Technologies_Logo.jpg

    Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 15, 2024, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

    Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
    Q2 Fiscal Year 2024 Results Press Release  2/15/2024 at 7:30 a.m.ET
    Q2 Fiscal Year 2024 Conference Call-Live   2/15/2024 at 11:00 a.m. ET
    US Toll Free Dial-In Number:               1-888-506-0062
    International Dial-In Number:              1-973-528-0011
    Participant Access Code:                   397299
    Q2 Fiscal Year 2024 Conference Call-Replay 2/15/2024-2/29/2024
    US Toll Free Dial-In Number:               1-877-481-4010
    International Dial-In Number:              1-919-882-2331
    Participant Access Code:                   49945
    

    The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.

    About PalatinPalatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website atwww.palatin.comand follow Palatin on Twitter at @PalatinTech.

    https://c212.net/c/img/favicon.png?sn=PH33382&sd=2024-02-09

    View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2024-results-teleconference-and-webcast-to-be-held-on-february-15-2024-302058387.html

    SOURCE Palatin Technologies, Inc.

    https://rt.newswire.ca/rt.gif?NewsItemId=PH33382&Transmission_Id=202402090730PR_NEWS_USPR_____PH33382&DateId=20240209

    COMTEX_447547187/1005/2024-02-09T07:30:32

    Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical...
    7:30a ET February 28 '24 PR Newswire
    Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and...
    7:30a ET February 15 '24 PR Newswire
    Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconfer...
    7:30a ET February 9 '24 PR Newswire
    Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 C...
    7:30a ET February 5 '24 PR Newswire
    Palatin Announces Closing of $10 Million Registered Direct Offering
    4:00p ET February 1 '24 PR Newswire
    Thinking about buying stock in Arcus Biosciences, Palatin Technologie...
    9:31a ET January 30 '24 PR Newswire
    Palatin Announces $10 Million Registered Direct Offering
    8:01a ET January 30 '24 PR Newswire

    Market data provided by News provided by